Innovative Strategies in the Management of Hypoplastic Left Heart Syndrome: A Multidisciplinary and Translational Approach

Main Article Content

Donaldo Emiliano Silva López
Andres Gerardo Herrera Jimenez
Isidro Fabián Martínez Valeriano
Geraldine Nieves Vázquez
Patricio Urrutia Alanis
Marian Anahí Rodríguez Carrillo

Abstract

Background: Hypoplastic Left Heart Syndrome (HLHS) represents one of the most severe congenital cardiac malformations, characterized by underdevelopment of left-sided heart structures, necessitating a complex surgical and medical management strategy. Despite advancements in staged palliation and neonatal care, outcomes remain suboptimal for a significant subset of patients. Recent progress in molecular biology, regenerative medicine, and surgical innovations offers novel approaches that may transform the clinical trajectory of these patients.


Objectives: This article explores emerging strategies for HLHS management, including stem cell therapy, tissue engineering, genomic medicine, hybrid procedures, and long-term monitoring protocols facilitated by artificial intelligence (AI).


Methods: A comprehensive review of contemporary literature was conducted, focusing on the translational application of novel therapies and their integration into current staged palliation frameworks.


Results: Early-stage studies demonstrate promise for stem cell therapies and myocardial regeneration in improving ventricular function. Advances in 3D printing and bioengineering have facilitated patient-specific surgical planning and the development of biocompatible grafts. Furthermore, AI-driven algorithms provide personalized risk assessment and optimized perioperative management strategies.


Conclusions: The integration of multidisciplinary and translational approaches offers an opportunity to redefine HLHS management, potentially improving survival and quality of life for affected individuals. However, further clinical trials and international collaboration are essential to establish these novel therapies as standard of care.

Article Details

How to Cite
Donaldo Emiliano Silva López, Andres Gerardo Herrera Jimenez, Isidro Fabián Martínez Valeriano, Geraldine Nieves Vázquez, Patricio Urrutia Alanis, & Marian Anahí Rodríguez Carrillo. (2025). Innovative Strategies in the Management of Hypoplastic Left Heart Syndrome: A Multidisciplinary and Translational Approach. International Journal of Medical Science and Clinical Research Studies, 5(1), 25–32. https://doi.org/10.47191/ijmscrs/v5-i01-05
Section
Articles

References

I. Park MK. Cyanotic congenital heart defects. In: Park MK, ed. Park’s Pediatric Cardiology for Practitioners. 6th ed. Philadelphia, PA: Elsevier, Saunders;2014. p. 206–89.

II. Feinstein JA, Benson W, Dubin AM, Cohen MS,Maxey DM, Mahle WT, et al. Hypoplastic left heart syndrome: current considerations and expectations. J Am Coll Cardiol. 2012; 59 Suppl 1: S1–42. Doi: 10.1016/j.jacc.2011.09.022.

III. Marshall AC. Cardiac catheterization and fetal intervention. In: Sellke FW, del Nido PJ, Swanson SJ, editors. Sabiston and Spencer Surgery of the Chest. 9th ed. Philadelphia, PA: Elsevier, Saunders; 2016. p. 1915–36.

IV. Allan LD, Sharland G, Tynan MJ. The natural history of the hypoplastic left heart syndrome. Int J Cardiol. 1989; 25(3): 341–3.

V. Danford DA, Cronican P. Hypoplastic left heart syndrome: progression of left ventricular dilation and dysfunction to left ventricular hypoplasia in utero. Am Heart J. 1992; 123(6): 1712–3.

VI. Frommelt MA. Challenges and controversies in fetal diagnosis and treatment: hypoplastic left heart syndrome. Clin Perinatol. 2014; 41(4): 787–98.

doi:10.1016/j.clp.2014.08.004.

VII. Webb GD, Smallhorn JF, Therrien J, Redington AN. In: Mann DL, Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed.

hiladelphia, PA: Elsevier, Saunders; 2015. p. 1391–445.

VIII. McElhinney DB, Vogel M, Benson CB, Marshall AC, Wilkins-Haug LE, Silva V, Tworetzky W. Assessment of left ventricular endocardial fibroelastosis in fetuses with aortic stenosis and evolving hypoplastic left heart syndrome. Am J Cardiol. 2010; 106(12): 1792–7.

doi: 10.1016/j.amjcard.2010.08.022.

IX. Friedman KG, Schidlow D, Freud L, Escobar-Diaz M, Tworetzky W. Left ventricular diastolic func tion and characteristics in fetal aortic stenosis. Am J Cardiol. 2014; 114(1): 122–7.

doi: 10.1016/j. amjcard.2014.04.013.

X. Mäkikallio K, McElhinney DB, Levine JC, Marx GR, Colan SD, Marshall AC, et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart

syndrome: patient selection for fetal intervention. Circulation. 2006; 113(11): 1401–5.

XI. Fraser CD, Carberry KE. Congenital Heart Disease. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL, editors. Sabiston Textbook of Surgery. 19th ed. Philadelphia, PA: Elsevier, Saunders; 2012. p. 1611–49.

XII. Graham EM, Shirali GS. Hypoplastic Left Heart Syndrome. In: Crawford MH, DiMarco JP, Paulus WJ, editors. Cardiology. 3rd ed. Philadelphia, PA: Elsevier Ltd.; 2010. P. 1519–28.

XIII. Mettler BA, Pigula FA. Hypoplastic Left Heart Syndrome. In: Sellke FW, del Nido PJ, Swanson SJ, editors. Sabiston and Spencer Surgery of the Chest. 9th ed. Philadelphia, PA: Elsevier, Saunders; 2016. p. 2295–312.

XIV. Steven JM, Marino BS, Jobes DR. Hypoplastic Left Heart Syndrome. In: Nichols DG, Cameron DE, editors. Critical Heart Disease in Infants and Children. 2nd ed. Philadelphia, PA: Elsevier, Mosby; 2006. p. 823–44.

Most read articles by the same author(s)

1 2 3 4 > >>